# Radiolabel Study In Healthy Volunteers For Insomnia-Targeting Drug

> **NCT00520663** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 8 (actual)

## Conditions studied

- Sleep Initiation and Maintenance Disorders

## Interventions

- **DRUG:** 14C-SB649868

## Key facts

- **NCT ID:** NCT00520663
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06-08
- **Primary completion:** 2007-08-10
- **Final completion:** 2007-08-10
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2017-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00520663

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00520663, "Radiolabel Study In Healthy Volunteers For Insomnia-Targeting Drug". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00520663. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*